Nav: Home

CT angiography appears better at predicting future risk for patients with chest pain

June 12, 2017

An analysis of diagnostic test results from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial - in which patients with stable chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy - showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle. The superiority of CT angiography primarily depended on its ability to reveal nonobstructive coronary artery disease. The report by a team led by Udo Hoffmann, MD, MPH, of the Massachusetts General Hospital (MGH) appears in the June 13 issue of Circulation.

"We do show that obstructive coronary artery disease and myocardial ischemia remain the strongest predictors of future cardiovascular events, but for the first time, in a randomized comparison we demonstrate the ability of CT angiography (CTA) to identify a large group of at-risk patients who would have been missed by functional stress testing," says Hoffmann, who is director of the MGH Cardiac MR PET CT Program. "This not only provides important information for physicians making choices regarding which test to perform but also suggests that implementing lifestyle changes and potentially the use of statin drugs may lower the risk of future clinical events for patients with nonobstructive disease."

The PROMISE trial was conducted at 193 centers across North America to determine whether a care strategy starting with coronary CTA, which reveals the structure of blood vessels supplying the heart, or a strategy starting with functional testing, measures such as stress testing or echocardiography that reflect how well the heart muscle is working, provided better guidance for clinical decisions regarding patients with chest pain. Those results, reported in a 2015 New England Journal paper, found similar outcomes for both strategies in terms of the incidence of future cardiovascular events.

The current study directly analyzed associations between the results of all diagnostic tests and the risk of future cardiac events in around 9,100 of the more than 10,000 patients in the PROMISE trial. The most important result indicated that the ability of coronary CTA to identify nonobstructive coronary artery disease - a less-than-70-percent narrowing of a coronary artery - identifies an at-risk group of patients not found by functional testing. In fact, most of the cardiovascular events during the study's two-year follow-up period occurred in patients not initially diagnosed with coronary artery obstruction. While functional testing on its own was inferior to CTA, combining the results of functional testing with traditional cardiovascular risk factors - such as cholesterol levels, blood pressure and smoking status - significantly improved its prognostic value.

"While these observational data cannot prove that treating patients based on the results of CTA testing will automatically result in better health outcomes, they do provide new information enabling a more informed choice of testing for patients with stable chest pain, especially for predicting future cardiovascular risk." says Hoffmann, who is a professor of Radiology at Harvard Medical School. "Future studies also need to determine whether more detailed analysis of exercise parameters in functional testing could improve its prognostic ability; but it's reassuring that both strategies can provide important prognostic information for patients and their physicians."
The co-authors of the Circulation paper are Maros Ferencik, MD, PhD, Oregon Health and Science University; James E. Udelson, MD, Tufts University School of Medicine; Michael H. Picard, MD, Massachusetts General Hospital; Quynh A. Truong, MD, MPH, Weill Cornell Medical College; John F. Heitner, MD, New York Methodist Hospital; Patricia A. Pellikka, MD, Mayo Clinic; Jean-Claude Tardif, MD, University of Montreal; Matthew Budoff, MD, Los Angeles Biomedical Research Institute; George Nahhas, MD, Beaumont Hospital-Dearborn; Benjamin Chow, MD, Ottawa Heart Institute; and Manesh R. Patel, MD, Megan Huang, PhD, Michael Pencina, PhD, Daniel B. Mark, MD, MPH, Christopher B. Fordyce, MD, Andrzej S. Kosinski, PhD, Kerry L. Lee, PhD, and Pamela S. Douglas, MD, Duke University School of Medicine. The study was supported by National Heart, Lung and Blood Institute grants R01 HL098237, R01 HL098236, R01 HL98305 and R01 HL098235.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $800 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, genomic medicine, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The MGH topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals and earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2016 the MGH was once again named to the Honor Roll in the U.S. News & World Report list of "America's Best Hospitals.

Massachusetts General Hospital

Related Chest Pain Articles:

More isn't better when it comes to evaluating chest pain
New and more effective tests are needed to help predict heart attacks and other major cardiac events in patients with chest pain, the second most common reason for emergency department visits in the US.
Artificial intelligence could prevent unneeded tests in patients with stable chest pain
Artificial intelligence (AI) could prevent unnecessary diagnostic tests in patients with stable chest pain, according to research presented today at ICNC 2019.
Kaiser Permanente improves emergency care for patients with chest pain
Emergency physicians at Kaiser Permanente hospitals in Southern California reduced hospital admissions and cardiac stress testing by using new criteria to assess the level of risk patients with chest pain have for subsequent cardiac events.
Treatment for underdiagnosed cause of debilitating chest pain
Researchers find an effective way to treat an underdiagnosed condition that can cause heart attack and heart-attack-like symptoms.
Diagnostic protocol effective in identifying ED patients with acute chest pain
A relatively new accelerated diagnostic protocol is effective in identifying emergency department patients with acute chest pain who can be safely sent home without being hospitalized or undergoing comprehensive cardiac testing, according to researchers at Wake Forest Baptist Medical Center.
More Chest Pain News and Chest Pain Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...